Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


28.01.2019

1 Arch Pediatr
1 Arch Virol
2 BMJ
1 Clin Infect Dis
2 J Infect Dis
3 J Virol
1 MMWR Morb Mortal Wkly Rep
1 Nat Immunol
4 Pediatrics
6 PLoS One
20 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Pediatr

  1. MARIEN AG, Hochart A, Lagree M, Diallo D, et al
    Parental acceptance of an intranasal vaccine: Example of influenza vaccine.
    Arch Pediatr. 2019 Jan 15. pii: S0929-693X(18)30237.
    PubMed     Text format     Abstract available


    Arch Virol

  2. HU J, Liang Y, Hu Z, Wang X, et al
    Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Arch Virol. 2019 Jan 22. pii: 10.1007/s00705-018-04142.
    PubMed     Text format     Abstract available


    BMJ

  3. IACOBUCCI G
    Vaccination: "fake news" on social media may be harming UK uptake, report warns.
    BMJ. 2019;364:l365.
    PubMed     Text format    

  4. HOPKINS TANNE J
    Measles: two US outbreaks are blamed on low vaccination rates.
    BMJ. 2019;364:l312.
    PubMed     Text format    


    Clin Infect Dis

  5. GREENWOOD B
    Sustaining Protection Against Epidemic Meningitis in Africa After Vaccination.
    Clin Infect Dis. 2019;68:444-445.
    PubMed     Text format    


    J Infect Dis

  6. BEDNARCZYK RA, Ellingson MK, Omer SB
    Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
    J Infect Dis. 2019 Jan 17. pii: 5265326. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. GILKEY MB, Margolis MA
    Human Papillomavirus Vaccination Coverage Gaps in Young Adolescents.
    J Infect Dis. 2019 Jan 17. pii: 5265336. doi: 10.1093.
    PubMed     Text format    


    J Virol

  8. ZOU C, Murakoshi H, Kuse N, Akahoshi T, et al
    Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    J Virol. 2019 Jan 23. pii: JVI.02142-18. doi: 10.1128/JVI.02142.
    PubMed     Text format     Abstract available

  9. MARIN MQ, Perez P, Ljungberg K, Sorzano COS, et al
    Potent Anti-Hepatitis C (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-launched RNA Replicons and MVA-HCV.
    J Virol. 2019 Jan 23. pii: JVI.00055-19. doi: 10.1128/JVI.00055.
    PubMed     Text format     Abstract available

  10. BURTON S, Spicer LM, Charles TP, Gangadhara S, et al
    Clade C HIV-1 envelope vaccination regimens differ in their ability to elicit antibodies with moderate neutralization breadth against genetically diverse tier 2 HIV-1 envelope variants.
    J Virol. 2019 Jan 16. pii: JVI.01846-18. doi: 10.1128/JVI.01846.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep


  11. QuickStats: Percentage* of Adults Aged 18-64 Years Who Had an Influenza Vaccination(dagger) in the Past 12 Months, by Sex and Current Asthma Status( section sign) - National Health Interview Survey,( paragraph sign) 2017.
    MMWR Morb Mortal Wkly Rep. 2019;68:48.
    PubMed     Text format    


    Nat Immunol

  12. FEHERVARI Z
    Vaccine sex differences.
    Nat Immunol. 2019;20:111.
    PubMed     Text format    


    Pediatrics

  13. HUDA MN, Ahmad SM, Alam MJ, Khanam A, et al
    Bifidobacterium Abundance in Early Infancy and Vaccine Response at 2 Years of Age.
    Pediatrics. 2019 Jan 23. pii: peds.2018-1489. doi: 10.1542/peds.2018-1489.
    PubMed     Text format     Abstract available

  14. SHAH PD, Calo WA, Gilkey MB, Boynton MH, et al
    Questions and Concerns About HPV Vaccine: A Communication Experiment.
    Pediatrics. 2019 Jan 22. pii: peds.2018-1872. doi: 10.1542/peds.2018-1872.
    PubMed     Text format     Abstract available

  15. SPINNER C, Ding L, Bernstein DI, Brown DR, et al
    Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.
    Pediatrics. 2019 Jan 22. pii: peds.2018-1902. doi: 10.1542/peds.2018-1902.
    PubMed     Text format     Abstract available

  16. ALIABADI N, Wikswo ME, Tate JE, Cortese MM, et al
    Factors Associated With Rotavirus Vaccine Coverage.
    Pediatrics. 2019 Jan 17. pii: peds.2018-1824. doi: 10.1542/peds.2018-1824.
    PubMed     Text format     Abstract available


    PLoS One

  17. ROSANOWSKI SM, Carpenter TE, Adamson D, Rogers CW, et al
    An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country.
    PLoS One. 2019;14:e0210885.
    PubMed     Text format     Abstract available

  18. PRIMO ME, Thompson CS, Valentini BS, Sarli M, et al
    Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle.
    PLoS One. 2019;14:e0211149.
    PubMed     Text format     Abstract available

  19. HOULE SKD, Eurich DT
    Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada.
    PLoS One. 2019;14:e0211006.
    PubMed     Text format     Abstract available

  20. JIANG H, Huai Y, Chen H, Uyeki TM, et al
    Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012.
    PLoS One. 2018;13:e0201312.
    PubMed     Text format     Abstract available

  21. NIX EB, Choi J, Anthes C, Gaultier GN, et al
    Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    PLoS One. 2018;13:e0201282.
    PubMed     Text format     Abstract available

  22. OGBUANU IU, Li AJ, Anya BM, Tamadji M, et al
    Can vaccination coverage be improved by reducing missed opportunities for vaccination? Findings from assessments in Chad and Malawi using the new WHO methodology.
    PLoS One. 2019;14:e0210648.
    PubMed     Text format     Abstract available


    Vaccine

  23. KOLE S, Qadiri SSN, Shin SM, Kim WS, et al
    PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30042.
    PubMed     Text format     Abstract available

  24. GIORGAKOUDI K, O'Sullivan C, Heath PT, Ladhani S, et al
    Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Vaccine. 2018;36:7033-7042.
    PubMed     Text format     Abstract available

  25. GIUFRE M, Fabiani M, Cardines R, Riccardo F, et al
    Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016.
    Vaccine. 2018;36:6615-6622.
    PubMed     Text format     Abstract available

  26. MARLOW R, Finn A, Rodrigues F
    Lack of impact of rotavirus vaccination on childhood seizure hospital attendances in Portugal - An interrupted time series analysis.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30055.
    PubMed     Text format    

  27. WOODS CW, Sanchez AM, Swamy GK, McClain MT, et al
    An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.
    Vaccine. 2019 Jan 18. pii: S0264-410X(18)31699.
    PubMed     Text format     Abstract available

  28. WOUTERS I, Desmet S, Van Heirstraeten L, Blaizot S, et al
    Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium.
    Vaccine. 2019 Jan 19. pii: S0264-410X(19)30049.
    PubMed     Text format     Abstract available

  29. LEDOV VA, Golovina ME, Markina AA, Knirel YA, et al
    Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.
    Vaccine. 2019 Jan 19. pii: S0264-410X(19)30048.
    PubMed     Text format     Abstract available

  30. ROBERTSON CA, Hedrick J, Bassily E, Greenberg DP, et al
    Persistence of bactericidal antibodies 4years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D).
    Vaccine. 2019 Jan 19. pii: S0264-410X(19)30039.
    PubMed     Text format     Abstract available

  31. ZHANG D, Jiang N, Chen Q
    Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice.
    Vaccine. 2019 Jan 19. pii: S0264-410X(18)31729.
    PubMed     Text format     Abstract available

  32. HADDISON EC, Ngono D, Kouamen GT, Kagina BM, et al
    Successful polio supplementary immunisation activities in a security compromised zone - Experiences from the Southwest region of Cameroon.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31356.
    PubMed     Text format     Abstract available

  33. YUNG BS, Pugh H, Generotti AA, Phanhthilath N, et al
    Novel IFN-gamma ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30037.
    PubMed     Text format     Abstract available

  34. LALSIAMTHARA J, Senevirathne A, Lee JH
    Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs.
    Vaccine. 2019 Jan 17. pii: S0264-410X(19)30074.
    PubMed     Text format     Abstract available

  35. STRIJBOS E, Tannemaat MR, Alleman I, de Meel RHP, et al
    A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis.
    Vaccine. 2019 Jan 16. pii: S0264-410X(19)30038.
    PubMed     Text format     Abstract available

  36. LANDAZABAL CS, Moro PL, Lewis P, Omer SB, et al
    Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.
    Vaccine. 2019 Jan 16. pii: S0264-410X(18)31641.
    PubMed     Text format     Abstract available

  37. DEGAREGE A, Krupp K, Fennie K, Srinivas V, et al
    An integrative behavior theory derived model to assess factors affecting HPV vaccine acceptance using structural equation modeling.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30046.
    PubMed     Text format     Abstract available

  38. BIANCO A, Mascaro V, Zucco R, Pavia M, et al
    Parent perspectives on childhood vaccination: How to deal with vaccine hesitancy and refusal?
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30033.
    PubMed     Text format     Abstract available

  39. XU L, Li Z, Su Z, Yang Y, et al
    Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30054.
    PubMed     Text format     Abstract available

  40. SMITH GP, Jain-Gupta N, Alqublan H, Dorneles EMS, et al
    Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30051.
    PubMed     Text format     Abstract available

  41. BOCCALINI S, Tacconi FM, Lai PL, Bechini A, et al
    Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30026.
    PubMed     Text format     Abstract available

  42. MUNIRA SL, Hendriks JT, Atmosukarto II, Friede MH, et al
    A cost analysis of producing vaccines in developing countries.
    Vaccine. 2019 Jan 14. pii: S0264-410X(18)31575.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: